Company filings profile · CIK 0001937993

Cadrenal Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Cadrenal Therapeutics, Inc. (CVKD): 18 filings in the last 90 days vs 24 in the prior 90 (filing-velocity cooling ↓ · 0.75×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 8, 2026. Source-linked, daily-refreshed.

Material 8-K events — Cadrenal Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 7, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Sep 29, 2026Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits↗
Aug 31, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 13, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Jul 21, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Jul 17, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
Jul 10, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
Jul 1, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits↗
Jun 29, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
Jun 18, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Jun 3, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
May 7, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Apr 30, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗

Watch Cadrenal Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jul 1, 20264↗
Jun 26, 20264↗
Jun 24, 20264↗
Jun 18, 20264↗
Jun 15, 20264↗
Jun 10, 20264↗
Jun 5, 20264↗
Jun 2, 20264↗
May 29, 20264↗
May 26, 20264↗
Dec 31, 20254↗

Recent filings

FiledFormDetail
Oct 7, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Sep 29, 20268-K Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits ↗
Sep 3, 2026S-8 REGISTRATION STATEMENT ↗
Aug 31, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Aug 13, 202610-Q QUARTERLY REPORT ↗
Aug 13, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Aug 7, 2026SCHEDULE 13G ↗
Aug 3, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS ↗
Aug 3, 2026ARS FORM ARS ↗
Aug 3, 2026DEF 14A PROXY STATEMENT ↗
Jul 23, 2026PRE 14A PROXY STATEMENT ↗
Jul 21, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Jul 20, 2026EFFECT Item ; Item ; Item ↗
Jul 20, 2026424B3 PROSPECTUS ↗
Jul 17, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Jul 15, 2026D Item 06b ↗
Jul 13, 2026S-3 REGISTRATION STATEMENT ↗
Jul 10, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Jul 1, 20264 ↗
Jul 1, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits ↗
Jun 29, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Jun 26, 20264 ↗
Jun 24, 20264 ↗
Jun 18, 20264 ↗
Jun 18, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Jun 15, 20264 ↗
Jun 15, 2026144 ↗
Jun 10, 20264 ↗
Jun 5, 20264 ↗
Jun 3, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Jun 2, 20264 ↗
May 29, 20264 ↗
May 26, 20264 ↗
May 11, 2026144 ↗
May 7, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
May 7, 202610-Q QUARTERLY REPORT ↗
Apr 30, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Apr 29, 2026EFFECT Item ; Item ; Item ↗
Apr 29, 2026424B3 PROSPECTUS ↗
Apr 27, 2026CORRESP ↗